Overview

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

Status:
Completed
Trial end date:
2019-07-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of pimavanserin for the treatment of depression in adults with Parkinson's disease.
Phase:
Phase 2
Details
Lead Sponsor:
ACADIA Pharmaceuticals Inc.
Treatments:
Pimavanserin